Geneoscopy key facts
as of Oct 2026- Developer of a molecular diagnostic platform designed to prevent, detect, and monitor gastrointestinal diseases through noninvasive testing.
- Geneoscopy is valued at approximately $440.0M as of Oct 2026, set at its later-stage round, Jan 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $218.4M across 2 recorded rounds; the latest was Later Stage VC ($50.5M) in May 2021.
- Notable investors include Dorm Room Fund, Morningside Group, Cultivation Capital, Labcorp Venture Fund, iSelect Fund — 24 tracked in total.
- 1 investment vehicle was formed to buy Geneoscopy shares in the last 12 months, reporting $802K sold to 22 investors, per SEC Form D filings.
- Geneoscopy has filed 2 Form Ds with the SEC since 2019, most recently Nov 2021 ($50.5M sold to 85 investors).
- Status: Privately Held (backing).
Valued at $440.0M at its later-stage round, Jan 2025. Nothing has traded since.
- ·The complete investor list: 24 names
- ·Watch Geneoscopy: the Monday email on marks, rounds and moves
Geneoscopy funding rounds
2 roundsVehicles formed to buy Geneoscopy shares
secondary demand · SEC Form D filingsIn the last 12 months, 1 investment vehicle were formed to buy Geneoscopy shares, reporting $802K sold to 22 investors. Most recent filing Jan 2026.
Membership and data by Private Market View
Who backs Geneoscopy
24+Geneoscopy valuation
Geneoscopy was valued at $440 million at its later-stage round in Jan 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Geneoscopy raised?
Geneoscopy has raised $218 million in total; 2 of its rounds are on record. The largest on record was a $7.9 million early-stage round in Sep 2019; the most recent was a $50.5 million later-stage round in May 2021.
Geneoscopy has filed 2 Form Ds with the SEC since 2019, most recently in Nov 2021 ($50.5 million sold to 85 investors).
Institutional holders and vehicles
In the last 12 months, 1 investment vehicle was formed to buy Geneoscopy shares, reporting $801,750 sold to 22 investors, per SEC Form D filings (most recent Jan 2026).
Geneoscopy investors
24 investors are on record for Geneoscopy, including Dorm Room Fund, Morningside Group, Cultivation Capital and Labcorp Venture Fund. By type, the record holds 7 venture capital firms, 1 family office and 1 hedge fund. The later-stage round in May 2021 drew 85 investors.
About Geneoscopy
Developer of a molecular diagnostic platform designed to prevent, detect, and monitor gastrointestinal diseases through noninvasive testing. The company's platform offers stool-derived eukaryotic RNA technology with molecular analysis of gastrointestinal biology, enabling healthcare providers to access safer, more convenient disease screening and monitoring that supports earlier detection and informed care decisions.
- Sector
- Healthcare
- HQ
- Saint Louis, MO, United States
- Founded
- 2015
- Employees
- 67
- Website
- geneoscopy.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.